awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45961010-59C34C1F-0979-44EF-952D-FCD27255FCCD
Q45961010-59C34C1F-0979-44EF-952D-FCD27255FCCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45961010-59C34C1F-0979-44EF-952D-FCD27255FCCD
Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.
P2860
Q45961010-59C34C1F-0979-44EF-952D-FCD27255FCCD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45961010-59C34C1F-0979-44EF-952D-FCD27255FCCD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dba6d6d35244e51d4f3c2d4098b28e614415c059
P2860
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res